Investigated event: Influence on cell viability
| Name | Value |
|---|---|
| Compound | MLS-2384 |
| Investigated event | Influence on cell viability |
| Experiment type | MTT |
| Concentration | 2.50 µM |
| Cell line | HepG2 |
| Organism | Homo sapiens |
| Animal model | |
| STAT protein | |
| Other |
Reference
MLS-2384, a new 6-bromoindirubin derivative with dual JAK/Src kinase inhibitory activity, suppresses growth of diverse cancer cells. Cancer biology & therapy Lucy Liu, Nicolas Gaboriaud, Konstantina Vougogianopoulou, Yan Tian, Jun Wu, Wei Wen, Leandros Skaltsounis, Richard Jove, 15, 2, None, 2013-11-01, 10.4161/cbt.26721
DOI: 10.4161/cbt.26721
PUBMED: 24100507
PMCID: PMC3928133